• Drugs for Correcting Water Electrolyte and Acidbase Disturbances, Glucerna
    Dosage form: Suspension
    Strength: 1.0cal
    Indications/Special comments: Nutritional deficiency (prophylaxsis and treatment).
    Dosage Administration: Detemined by the physician on advice of the dietician.
    View full drug info
  • Cardiovascular Drugs, Guanfacine
    Dosage form: Tablet (ER)
    Strength: 1mg, 2mg
    Indications/Special comments: Indicated in the management of hypertension. Guanfacine may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.
    Dosage Administration: Given alone or in combination with another antihypertensive drug is 1 mg daily given at bedtime to minimize somnolence. If after 3 to 4 weeks of therapy 1 mg does not give a satisfactory result, a dose of 2 mg may be given, although most of the effect of Guanfacine is seen at 1 mg Higher daily doses have been used, but adverse reactions increase significantly with doses above 3 mg/day.
    View full drug info
  • Cardiovascular Drugs, Glyceryl Trinitrate (Nitroglycerine)
    Dosage form: Tablet (sublingual)
    Strength: 0.6mg
    Indications/Special comments: Prophylaxis and treatment of angina.
    Dosage Administration: Adult: 0.3 - 0.6mg repeated at five-minute intervals for the maximum of 3 doses in 15 minutes, may also use prophylactically 5 - 10 minutes prior to activities which may provoke an attack.
    View full drug info
  • Cardiovascular Drugs, Glyceryl Trinitrate (Nitroglycerine)
    Dosage form: Injection
    Strength: 5mg/ml
    Indications/Special comments: Prophylaxis and treatment of angina.
    Dosage Administration: IV: 5mcg/minute, increase by 5mcg/minute every 3 - 5 minutes to 20mcg/minute; if no response at 20mcg/minute increase by 10mcg/minute every 3 - 5 minutes, up to 200mcg/minute.
    View full drug info
  • Cardiovascular Drugs, Gemfibrozil
    Dosage form: Capsule
    Strength: 300mg
    Indications/Special comments: Treatment of hypertriglyceridemia in WHO types IV and V hyperlipidemia for patients who are at great risk for pancreatitis and who have not responded to dietary interventions.
    Dosage Administration: Adult: Initially, 300mg twice daily, increased to 600mg twice daily, 30 minutes before the morning and evening meals. Dosage range, 0.9 - 1.5g daily in 2 divided doses.
    View full drug info
  • Anxiolytics, Sedatives, Hypnotics and Antipsychotics, Galantamine
    Dosage form: Tablet
    Strength: 8mg
    Indications/Special comments: Mild to moderate dementia/neurocognitive disorder of the Alzheimer's type.
    Dosage Administration: Adults: Immediate-release tablets– 4mg twice daily initially, dose increments of 4mg should be made at 4 wk intervals, up to 12mg twice daily. Doses up to 16mg twice daily have been used (range 16 – 32mg/day;
    View full drug info
  • Anxiolytics, Sedatives, Hypnotics and Antipsychotics, Galantamine
    Dosage form: Capsule ER
    Strength: 8mg
    Indications/Special comments: Mild to moderate dementia/neurocognitive disorder of the Alzheimer's type.
    Dosage Administration: Adults: Extended-release capsules– 8mg/day as a single dose in the morning, may be increase to 16mg/day after 4 wk, then up to 24mg/day after 4 wk; increments based on benefit/tolerability.
    View full drug info
  • Antivirals, Ganciclovir
    Dosage form: Powder for Injection
    Strength: 500mg
    Indications/Special comments: Treatment of slight or life threatening cytomegalovirus (CMV) infections in immuno-compromised patients, and for the prevention of CMV disease in transplant recipients.
    Dosage Administration: Adult: CMV retinitis: IV infusion: initially 5mg/kg 12 hourly infused at a constant rate over 1 hour (10mg/kg/day) for 14 - 21 days. Maintenance: IV infusion 6mg/kg/day for 5 days /week; or 5mg/kg/day for 7 days/week.
    View full drug info
  • Antineoplastics and Related Agents, Granisetron
    Dosage form: Injection
    Strength: 1mg/ml
    Indications/Special comments: Prophylaxis of chemotherapy-related emesis; prophylaxis of nausea and vomiting associated with radiation therapy, including total body irradiation and fractionated abdominal radiation; prophylaxis of postoperative nausea and vomiting (PONV).
    Dosage Administration: Adult: Prophylaxis of chemotherapy-related emesis: 2mg once daily up to 1 hour before chemotherapy or 1mg twice daily; the first 1mg dose should be given up to 1 hour before chemotherapy. Prophylaxis of radiation therapy-associated emesis: 2mg once daily given 1 hour before radiation therapy
    View full drug info
  • Antineoplastics and Related Agents, Granisetron
    Dosage form: Capsule
    Strength: 1mg
    Indications/Special comments: Prophylaxis of chemotherapy-related emesis; prophylaxis of nausea and vomiting associated with radiation therapy, including total body irradiation and fractionated abdominal radiation; prophylaxis of postoperative nausea and vomiting (PONV).
    Dosage Administration: Adult: Prophylaxis of chemotherapy-related emesis: 2mg once daily up to 1 hour before chemotherapy or 1mg twice daily; the first 1mg dose should be given up to 1 hour before chemotherapy. Prophylaxis of radiation therapy-associated emesis: 2mg once daily given 1 hour before radiation therapy
    View full drug info